시장보고서
상품코드
1179900

세계의 전기 진단 기기 시장(2023-2030년)

Global Electro-Diagnostic Devices Market - 2023-2030

발행일: | 리서치사: DataM Intelligence | 페이지 정보: 영문 200 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

제품 소개 증가, 노년 인구 증가, 관련된 만성질환은 예측기간 중 세계의 전기 진단 기기 시장 성장을 지지하고 있습니다.

목차

제1장 조사 방법과 조사 범위

  • 조사 방법
  • 조사 목적 및 조사 범위

제2장 시장 정의와 개요

제3장 주요 요약

제4장 시장 역학

  • 시장 영향요인
    • 성장 촉진요인
    • 성장 억제요인
    • 비지니스 기회
    • 영향 분석

제5장 산업 분석

  • Porter's Five Forces 분석
  • 공급망 분석
  • 규제 분석

제6장 COVID-19의 분석

  • COVID-19의 시장 분석
    • COVID-19 이전 시장 시나리오
    • COVID-19 현재 시장 시나리오
    • COVID-19 이후 또는 향후 시나리오
  • COVID-19 중에서의 가격 역학
  • 수요-공급 스펙트럼
  • 팬데믹 동안 시장과 관련된 정부 대처
  • 제조업체의 전략적 대처
  • 정리

제7장 제품 종류별

  • 심전도(ECG)
  • 근전도(EMG)
  • 뇌전도(EEG)
  • 신경전도(NCS)
  • 망막전도(ERG)
  • 위전도(EGG)

제8장 제품별 모빌리티

  • 고정형
  • 휴대용

제9장 최종사용자별

  • 병원·클리닉
  • 외래 수술 센터(ASC)
  • 재택의료
  • 진단 센터

제10장 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 남미
    • 브라질
    • 아르헨티나
    • 기타 남미
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카

제11장 경쟁 상황

  • 주요 전개와 전략
  • 기업 점유율 분석
  • 제품 벤치마크

제12장 기업 개요

  • GE Healthcare
    • 기업 개요
    • 제품 포트폴리오와 설명
    • 주요 하이라이트
    • 재무 개요
  • Medtronic
  • Abbott
  • Boston Scientific
  • Bionet America, Inc.
  • Philips Healthcare
  • Cardinal Health
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Becton, Dickinson and Company

제13장 DataM

KSM 23.01.19

Market Overview

The global electro-diagnostic devices market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period (2023-2030).

Electro-diagnostics is a testing technique that estimates the body's speed or extent of electrical activity. Electro-diagnostics equipment examines muscle and nerve impulses' electrical conduction or activity. These devices help practitioners or physicians recommend diagnoses for patients such as myopathy, neuropathy, neuromuscular junction disorder, and plexopathy. The major electro-diagnostic study includes nerve conduction studies (NCS), somatosensory evoked potential studies (SSEPs), and electromyography (EMG).

Market Dynamics

The rising product introductions, growing geriatric population and associated chronic diseases are boosting the global electro-diagnostic devices market growth in the forecast period.

The increasing product launches are fueling growth in the market.

The increased market developments, growing geriatric population and chronic diseases are boosting the global Electro-Diagnostic Devices market growth in the forecast period. For instance, in September 2020, AliveCor, a US FDA-approved personal electrocardiogram (ECG) technology firm, today entered the Indian market with the introduction of its clinically-validated personal ECG device, KardiaMobile 6L, the world's only six-lead, FDA-cleared personal ECG device and can detect three most common arrhythmias, the atrial fibrillation (AFib), bradycardia, and tachycardia. Since these conditions require regular monitoring, the patients can test themselves for these arrhythmias at home. The KardiaMobile 6L can record a medical-grade ECG in only 30 seconds. Also, in October 2022, Dozee, India's first contactless remote patient monitoring (RPM) company, declared about launching an ambulatory electrocardiogram (ECG) patch to monitor cardiovascular disease (CVD) patients.

Moreover, in July 2020, Brain Scientific Inc., a medical device and technology company delivering products and solutions associated with the brain, including neurology, AI and machine learning, improved its disposable EEG headset, NeuroCap, with new features. Likewise, in January 2022, Cadwell launched the Pudendal (Pelvic Floor) Stimulating and Recording Electrode and Cable in the United States. The pudendal electrode, fabricated by Spes Medica, is developed with the Sierra Summit system to assess pudendal nerve terminal motor latency (PNTML) in the anal sphincter. Therefore, the data above indicates that the increased product introductions boost the global electro-diagnostic devices market during the forecasted period.

The high cost of the equipment is expected to hamper global electro-diagnostic devices market growth.

However, one of the important factors hampering the market growth is the high setup and upkeep costs of electro-diagnostic devices. For instance, handheld ECG machines can be $500, and laptop-based ECG machines cost about $1000-$2,000. At the same time, portable ECG machines cost between $1,000-$3,000 on average.

COVID-19 Impact.

The COVID-19 pandemic moderately impacted the global electro-diagnostic devices market. Most diagnostics procedures were canceled or postponed during the early pandemic day since the major focus was on COVID-19. Still, later with the decrease in cases of COVID-19, electro-diagnosis procedures were performed with extreme precautions. For instance, in early 2020, the cancellation of elective medical procedures in the United States, including non-urgent outpatient and inpatient electro-diagnostic (EDx) studies, was observed. While certain regions subsequently showed a decrease in daily new cases, EDx laboratories were reopened under the direction of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM). Furthermore, COVID-19 led to the development of personalized monitoring devices which positively impacted the market. Therefore, from the data mentioned, COVID-19 had a mixed impact on the global electro-diagnostic devices market.

Segment Analysis

Electrocardiography (ECG) devices are expected to dominate the electro-diagnostic devices market throughout the forecast period (2022-2029).

Electrocardiography (ECG) product is estimated to hold most of the market share throughout the forecast period. The growing cases of cardiovascular diseases worldwide ensure that the electrocardiography (ECG) devices segment grows at a high CAGR during the forecast period. For instance, according to the WHO, cardiovascular diseases (CVDs) are the major cause of death globally, taking over 17.9 million lives annually. Over 75% of CVD-related deaths happen in low- and middle-income countries. The World Heart Federation forecasts over 23 million CVD-related deaths annually by 2030.

Furthermore, the increased initiatives by various entities to spread awareness about cardiac health are boosting segment growth in the forecasted period. For example, NHLBI, The Heart Truth, and organizations around the United States on National Wear Red Day marked each year on the first Friday in February to obtain greater awareness of heart disease as a leading cause of death for Americans. Also, on February 10, 2019, the Heart Foundation introduced the coordinated advertising and editorial 'Serial Killer' campaign in collaboration with News Corp Australia to point out to Australians that heart disease is the nation's leading cause of death. The campaign delivered Australians with an easy-to-use online tool, the Heart Age Calculator, to enable them to evaluate their own risk for heart disease and called on the Government to support the prevention of heart disease by supplying a Medicare advantage for Heart Health Checks.

Additionally, CDC run Million Hearts is a national endeavor to avert 1 million heart attacks and strokes in the period of five years. It concentrates on enforcing a small set of evidence-based preferences and targets that can enhance cardiovascular health for all. Therefore, from the mentioned data, it is estimated that the electrocardiography (ECG) devices segment will grow at a high CAGR throughout the forecast period.

Geographical Analysis

North America holds the largest market share of global electro-diagnostic devices.

North America is anticipated to hold most of the global electro-diagnostic devices market during the forecasted period (2022-2029) because of the increasing number of developed and well-staffed hospitals and increased healthcare expenditure in this region. For instance, according to the American Hospital Association, currently, over 6,093 hospitals have more than 920,531 staff bed capacity, which in 2022 had over 33,356,853 admissions generating $ 1,213,881,001,000 of expenditure. In addition, the growing geriatric population and related chronic disease cases in this region contribute to the region's dominance over the global electro-diagnostic device market. For example, according to the United States Census Bureau, over 54 million adults ages 65 and older living in the United States in 2021, accounting for around 16.5% of the nation's population. The number of older U.S. adults is growing. By 2050, the total number of adults ages 65 and older is projected to reach 85.7 million, making up around 20% of the overall U.S. population.

Furthermore, according to the CDC, six out of ten U.S. adults have at least one chronic disease. Moreover, according to the same source, approximately 697,000 people in the United States died from heart disease in 2020. The American Heart Association estimated that By 2035 over 130 million U.S. adults will have some heart disease. Thus, the mentioned data indicates that North America will dominate the global electro-diagnostic devices market in the forecast period.

Competitive Landscape

The global electro-diagnostic devices market is fairly consolidated, with selected key players accounting for the predominant market share. The major players with significant market share include Stryker Corporation, Becton, Dickinson and Company, Boston Scientific, Medtronic, Abbot, Bionet America, Inc., Philips Healthcare, Cardinal Health, GE Healthcare, and B. Braun Melsungen AG, among others. The key players focus on R&D, product innovation, and product outreach through distribution through local suppliers and distributors worldwide. For instance, in November 2022, Bionet America, Inc. announced its plan to restructure its diagnostics division to make around 300 million euros in savings by 2025.

GE Healthcare

Overview:

GE Healthcare is headquartered in Chicago, Illinois, United States, and was founded in 2004. It is a subsidiary of the American Multinational Conglomerate General Electric. It is a leading manufacturer and distributor of diagnostic imaging and radiopharmaceuticals for imaging modalities used in medical imaging procedures.

Product Portfolio:

GE Healthcare's product portfolio of electro-diagnostic devices has CARESCAPE B450 Monitor: The CARESCAPE B450 monitor functions seamlessly with the CARESCAPE ONE monitor or CARESCAPE Patient Data Module (PDM) and one additional e-module, delivering the ability to monitor patients with various insights. Portable and inexpensive, it's developed with emergency departments, surgery centers, and step-down units in mind.

The global electro-diagnostic devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Product Launches
      • 4.1.1.2. Growing Prevalence of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Electrocardiography (ECG)
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Electromyogram (EMG)
  • 7.4. Electroencephalography (EEG)
  • 7.5. Nerve Conduction (NCS)
  • 7.6. Electroretinography (ERG)
  • 7.7. Electrogastrography (EGG)

8. By Product Mobility

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
    • 8.1.2. Market Attractiveness Index, By Product Mobility
  • 8.2. Stationary
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Portable

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals and Clinics
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgical Centers (ASCs)
  • 9.4. Homecare
  • 9.5. Diagnostic Centers

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Mobility
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. GE Healthcare
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Medtronic
  • 12.3. Abbott
  • 12.4. Boston Scientific
  • 12.5. Bionet America, Inc.
  • 12.6. Philips Healthcare
  • 12.7. Cardinal Health
  • 12.8. B. Braun Melsungen AG
  • 12.9. Stryker Corporation
  • 12.10. Becton, Dickinson and Company

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제